These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 22729989)
1. Prolonged and symptomatic bradycardia following a single dose of fingolimod. Faber H; Fischer HJ; Weber F Mult Scler; 2013 Jan; 19(1):126-8. PubMed ID: 22729989 [TBL] [Abstract][Full Text] [Related]
2. Delayed fingolimod-associated asystole. Espinosa PS; Berger JR Mult Scler; 2011 Nov; 17(11):1387-9. PubMed ID: 21652609 [TBL] [Abstract][Full Text] [Related]
3. [Clinical significance of the cardiovascular effects of fingolimod treatment in multiple sclerosis]. Széplaki G; Merkely B Ideggyogy Sz; 2012 Nov; 65(11-12):369-76. PubMed ID: 23289171 [TBL] [Abstract][Full Text] [Related]
5. Melanoma occurring during treatment with fingolimod for multiple sclerosis: a case report. Conzett KB; Kolm I; Jelcic I; Kamarachev J; Dummer R; Braun R; French LE; Linnebank M; Hofbauer GF Arch Dermatol; 2011 Aug; 147(8):991-2. PubMed ID: 21844470 [No Abstract] [Full Text] [Related]
6. The real-life experience with cardiovascular complications in the first dose of fingolimod for multiple sclerosis. Fragoso YD; Arruda CC; Arruda WO; Brooks JB; Damasceno A; Damasceno CA; Finkelsztejn A; Finkelsztejn J; Gama PD; Giacomo MC; Gomes S; Goncalves MV; Matta AP; de Morais MM; Oliveira EM; Ribeiro Y; Sato HK; Tauil CB Arq Neuropsiquiatr; 2014 Sep; 72(9):712-4. PubMed ID: 25252236 [TBL] [Abstract][Full Text] [Related]
7. Delayed cardiac dysrhythmias after fingolimod administration. Rosini JM; Rajasimhan S; Fellows SE; Nomura JT Am J Emerg Med; 2015 Jul; 33(7):987.e1-3. PubMed ID: 25669873 [TBL] [Abstract][Full Text] [Related]
8. Overview and safety of fingolimod hydrochloride use in patients with multiple sclerosis. Ward MD; Jones DE; Goldman MD Expert Opin Drug Saf; 2014 Jul; 13(7):989-98. PubMed ID: 24935480 [TBL] [Abstract][Full Text] [Related]
9. Fingolimod-associated amenorrhea: a report of three cases. Alroughani R Mult Scler; 2014 Oct; 20(12):1662-4. PubMed ID: 24515730 [TBL] [Abstract][Full Text] [Related]
10. Severe auto-immune hemolytic anemia in a fingolimod-treated multiple sclerosis patient. Lysandropoulos AP; Benghiat F Mult Scler; 2013 Oct; 19(11):1551-2. PubMed ID: 23817558 [No Abstract] [Full Text] [Related]
11. Fingolimod for multiple sclerosis. Pelletier D; Hafler DA N Engl J Med; 2012 Jan; 366(4):339-47. PubMed ID: 22276823 [No Abstract] [Full Text] [Related]